Senzime ABSNZZF -1.06%71 Days Inventory is 164.28 as of Mar. 2026, which is 13% below its 10-year median of 188.29. GuruFocus rates SNZZF with a GF Score™ of 71/100 and a GF Value™ of $1.22 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Senzime AB ranks better than 62.21% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Senzime AB's Average Total Inventories for the
three
months ended in Mar. 2026 was $2.62 Mil. Senzime AB's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $1.46 Mil.
Hence, Senzime AB's Days Inventory for the
three
months ended in Mar. 2026 was 164.28.
The historical rank and industry rank for Senzime AB's Days Inventory or its related term are showing as below:
SNZZF'
s Days Inventory Range Over the Past 10 Years
Min: 45.43 Med: 188.29 Max: 351.77
Current: 150.52
During the past 13 years, Senzime AB's highest Days Inventory was 351.77. The lowest was 45.43. And the median was 188.29.
SNZZF's Days Inventory is ranked better than 62.21% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs SNZZF: 150.52
Senzime AB's Days Inventory
declined
from Mar. 2025 (194.22) to Mar. 2026 (164.28).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Senzime AB's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.56.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Senzime AB's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.05.
Senzime AB (OTCPK:SNZZF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Senzime AB's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Senzime AB's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Senzime AB Days Inventory Related Terms
Senzime AB Days Inventory Historical Data
* Premium members only.
The historical data trend for Senzime AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Senzime AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Senzime AB Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Senzime AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where Senzime AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Senzime AB (SNZZF) has a Days Inventory of 164.28 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Senzime AB and its competitors. This is 13% below median its historical median of 188.29. Over the past decade, Senzime AB's Days Inventory has ranged from 45.43 to 351.77. According to the industry distribution chart, Senzime AB ranks #297 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 37.8%.
Is Senzime AB's Days Inventory too high?
Senzime AB's current Days Inventory of 164.28 is 13% below median its 10-year median of 188.29. Over the past 10 years, this metric has ranged from a low of 45.43 to a high of 351.77. The Medical Devices & Instruments industry median Days Inventory is 179.60. Senzime AB's value of 164.28 is 8.5% below this industry median. Based on the distribution chart, Senzime AB ranks #297 out of 786 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Senzime AB has a GF Score™ of 71/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Senzime AB's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Senzime AB ranks #297 out of 786 companies for Days Inventory. This puts Senzime AB in the upper half of its industry. The industry median Days Inventory is 179.60. Senzime AB's value of 164.28 is 8.5% below this benchmark. Historically, Senzime AB's own Days Inventory has ranged from 45.43 to 351.77 over the past decade. While the company's 10-year median is 188.29 vs. the industry median of 179.60, Senzime AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Senzime AB's current Days Inventory of 164.28 is 8.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Senzime AB and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Senzime AB's current Days Inventory is 164.28, which is 13% below median its own 10-year median of 188.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senzime AB stock overvalued right now?
Based on GuruFocus' analysis, Senzime AB (SNZZF) is currently considered Possible Value Trap. The stock's GF Value™ is $1.22, compared to a current price of $0.47 — trading 61.2% below its estimated fair value. The current Days Inventory is 164.28, which is 13% below median its 10-year median of 188.29 and 8.5% below the Medical Devices & Instruments industry median of 179.60. Senzime AB's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Senzime AB (SNZZF), the current Days Inventory is 164.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Senzime AB (SNZZF) Overvalued in 2026?
Based on GuruFocus' analysis, Senzime AB stock appears to be undervalued.
The current stock price of $0.47 is trading 61.2% below its estimated GF Value™ of $1.22.
GuruFocus considers Senzime AB to be Possible Value Trap.
Key valuation signals for SNZZF:
Days Inventory: 164.28 (13% below median its 10-year median of 188.29)
GF Value™: $1.22 vs. price of $0.47 (61.2% below fair value)
Industry Position: 8.5% below the Medical Devices & Instruments median (#297 of 786)
No single metric tells the full story. See the SNZZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Senzime AB is a medical device company developing precision-based patient monitoring solutions for patients undergoing anesthesia. The company develops and markets precision-based monitoring systems for monitoring neuromuscular function and respiration during and after surgery, as well as for intensive care. Its product portfolio includes Next-generation TetraGraph, TetraGraph connectivity, TetraGraph for pediatric, Classic TetraGraph, and ExSpiron. The TetraGraph system is used in thousands of operating rooms internationally in university hospitals, public, private, military, and veterans hospitals. Senzime has direct sales resources in the USA and Germany and collaborates with distributors and licensees in its other main markets.
71GF Score
Get the complete analysis for SNZZF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNZZF has been successfully added to your 
